Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (501-510 of 517) with videos related to

Pageof 52
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 4, 2004
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush, Madhukar H Trivedi, Thomas J Carmody, et al.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysisLynn Boschloo, Ella Bekhuis, Erica S Weitz, et al.
JAMA Psychiatry|September 24, 2015
Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysisErica S Weitz, Steven D Hollon, Jos Twisk, et al.
Journal of Affective Disorders|December 26, 2024
Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial reportVictoria C de Leon, Rebecca M Allen, João Quevedo, et al.
Brain Stimulation|April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial reportCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
The Journal of Clinical Psychiatry|July 14, 2026
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study ReportVasilis C Hristidis, Victoria De Leon, Andrew D Van Der Vaart, et al.
Cell|December 18, 2007
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancerKlarisa Rikova, Ailan Guo, Qingfu Zeng, et al.
The American Journal of Psychiatry|November 3, 2010
Genome-wide association study of suicide attempts in mood disorder patientsRoy H Perlis, Jie Huang, Shaun Purcell, et al.
Brain Stimulation|December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trialA John Rush, Charles R Conway, Scott T Aaronson, et al.
Pageof 52

Showing results (501-510 of 517) with videos related to

Sort By:
Pageof 52
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 4, 2004
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush, Madhukar H Trivedi, Thomas J Carmody, et al.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysisLynn Boschloo, Ella Bekhuis, Erica S Weitz, et al.
JAMA Psychiatry|September 24, 2015
Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysisErica S Weitz, Steven D Hollon, Jos Twisk, et al.
Journal of Affective Disorders|December 26, 2024
Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial reportVictoria C de Leon, Rebecca M Allen, João Quevedo, et al.
Brain Stimulation|April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial reportCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
The Journal of Clinical Psychiatry|July 14, 2026
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study ReportVasilis C Hristidis, Victoria De Leon, Andrew D Van Der Vaart, et al.
Cell|December 18, 2007
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancerKlarisa Rikova, Ailan Guo, Qingfu Zeng, et al.
The American Journal of Psychiatry|November 3, 2010
Genome-wide association study of suicide attempts in mood disorder patientsRoy H Perlis, Jie Huang, Shaun Purcell, et al.
Brain Stimulation|December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trialA John Rush, Charles R Conway, Scott T Aaronson, et al.
Pageof 52